Free Trial

JPMorgan Chase & Co.'s Rating of Cencora on 11/10/2026

On November 10, 2026, JPMorgan Chase & Co. updated its outlook on Cencora (NYSE:COR) with the action "Boost Price Target", setting a price target of $413.00. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from JPMorgan Chase & Co.

DateCompanyAction
11/13/2026
NeuroPace, Inc. stock logo
NPCE
NeuroPace
Downgrade
11/12/2026
CytomX Therapeutics, Inc. stock logo
CTMX
CytomX Therapeutics
Boost Price Target
11/12/2026
Essent Group Ltd. stock logo
ESNT
Essent Group
Boost Price Target
11/12/2026
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
Boost Price Target
11/12/2026
Reformation Inc. stock logo
REF
Reformation
Boost Price Target
11/12/2026
BrightView Holdings, Inc. stock logo
BV
BrightView
Lower Price Target
More Ratings From JPMorgan Chase & Co.